C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
260/550.8
C07C 233/00 (2006.01) A61K 31/60 (2006.01)
Patent
CA 1151211
ABSTRACT The (R,R) optical isomer of labetalol, namely 5-{ (R)- -l-hydroxy-2-[(R)-l-methyl-3-phenylpropyl)amino]ethyl} sali- cylamide, and its pharmaceutically acceptable acid addi- tion salts, in a state substantially free of the correspon- ding (R,S), (S,R) and (S,S) optical isomers, are novel com- pounds with favourable therapeutic properties in compari- son with labetalol. They can be used in particular in the treatment of hypertension. The novel (R,R) optical isomer and its pharmaceutically acceptable acid addition salts can be prepared by removal of the protecting groups from an N,O-protected (R,R) opti- cal isomer or acid addition salt thereof, wherein the ba- sic nitrogen atom and the phenolic hydroxy group are pro- tected, preferably by hydrogenolytic removal of hydrogeno- lysable groups.
335885
Chang Wei
Gold Elijah H.
Schering Corporation
Swabey Ogilvy Renault
LandOfFree
Phenylalkylaminoethylsalicylamide, its preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalkylaminoethylsalicylamide, its preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalkylaminoethylsalicylamide, its preparation and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-820147